Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 10-11
Submit an article Journal homepage
435
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease

Ji Min LeeDepartment of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea;
,
Yoon Jae KimDepartment of Internal Medicine, Gachon University, Gil Medical Center, Incheon, Korea; Correspondence[email protected]
,
Kang-Moon LeeDepartment of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; Correspondence[email protected]
,
Hyuk YoonDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea;
,
Bo-In LeeDepartment of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Dae Bum KimDepartment of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea;
&
Donghoon KangDepartment of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
 show all
Pages 1280-1285 | Received 08 Jul 2018, Accepted 10 Sep 2018, Published online: 23 Oct 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

C. Jorissen, B. Verstockt, N. Schils, J. Sabino, M. Ferrante & S. Vermeire. (2021) Long-term clinical outcome after thiopurine discontinuation in elderly IBD patients. Scandinavian Journal of Gastroenterology 56:11, pages 1323-1327.
Read now

Articles from other publishers (9)

Nai‐Yu Chen, Chiao‐Hsiung Chuang, Yu‐Ching Chang, Yea‐Huei Kao Yang, Peng‐Hsu Chen & Ching‐Lan Cheng. (2023) Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study . Clinical Pharmacology & Therapeutics.
Crossref
Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein & David T Rubin. (2023) (Re)Appraising Remission in Ulcerative Colitis. Inflammatory Bowel Diseases 29:8, pages 1317-1326.
Crossref
Alex Arenas, María José Moreta, Ingrid Ordás, Agnès Fernández-Clotet, Berta Caballol, Marta Gallego, Alejandro Vara, Rebeca Barastegui, Angel Giner, Cristina Prieto, Maria Carme Masamunt, Roberto Candia & Elena Ricart. (2023) De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice. Gastroenterología y Hepatología.
Crossref
Annemay M. H. Stoker, Leslie Logghe, Mirjam C. M. van der Ende-van Loon, Erik J. Schoon, Ramon-Michel Schreuder, Arnold Stronkhorst & Lennard P. L. Gilissen. (2023) Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission. Clinical and Experimental Medicine.
Crossref
Cong Dai, Yi-Nuo Wang, Wen-Ning Tian, Yu-Hong Huang & Min Jiang. (2023) Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis. Revista Española de Enfermedades Digestivas.
Crossref
Guanglin Cui, Jon Florholmen & Rasmus Goll. (2022) Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?. Frontiers in Immunology 13.
Crossref
María José Casanova, María Chaparro, Óscar Nantes, José Manuel Benítez, María Rojas‐Feria, Jesús Castro‐Poceiro, José María Huguet, Albert Martín‐Cardona, Marta Aicart‐Ramos, Joan Tosca, María del Mar Martín‐Rodríguez, Carlos González‐Muñoza, Miriam Mañosa, Eduardo Leo‐Carnerero, Luis Javier Lamuela‐Calvo, Isabel Pérez‐Martínez, Luis Bujanda, Joaquín Hinojosa, Ramón Pajares, Federico Argüelles‐Arias, José Lázaro Pérez‐Calle, Gloria Esther Rodríguez‐González, Jordi Guardiola, Manuel Barreiro‐de Acosta & Javier P. Gisbert. (2021) Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study. Alimentary Pharmacology & Therapeutics 53:12, pages 1277-1288.
Crossref
Uday N. Shivaji, Alina Bazarova, Tamsin Critchlow, Samuel C. L. Smith, Olga Maria Nardone, Melanie Love, Joanne Davis, Subrata Ghosh & Marietta Iacucci. (2020) Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy. Therapeutic Advances in Gastroenterology 13, pages 175628482098121.
Crossref
Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon & Yoon Jae Kim. (2019) Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease. International Journal of Colorectal Disease 34:10, pages 1713-1721.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.